IMPLICATION OF DYRK1A, A CANDIDATE GENE FOR DOWN SYNDROME, IN ALZHEIMER'S TYPE PATHOLOGY AND CHARACTERIZATION OF THE NEUROPATHOLOGICAL AND COGNITIVE EFFECTS OF CYTOTOXIC PROTOFIBRILS FROM PEPTIDES DERIVED OF NATURAL AMYLOID PROTEINS IN DYRK1A MOUSE MODELS
